Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


11.03.2019

1 AIDS
3 Ann Intern Med
1 BMJ
15 Clin Infect Dis
5 Infect Immun
1 J Gen Virol
1 J Immunol
1 J Virol
1 JAMA
4 Lancet Infect Dis
1 Lancet Respir Med
1 MMWR Morb Mortal Wkly Rep
1 Pediatrics
6 PLoS One
1 Science
13 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS


  1. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination: Erratum.
    AIDS. 2019;33:771.
    PubMed     Text format    


    Ann Intern Med

  2. HVIID A, Hansen JV, Frisch M, Melbye M, et al
    Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
    Ann Intern Med. 2019 Mar 5. pii: 2727726. doi: 10.7326/M18-2101.
    PubMed     Text format     Abstract available


  3. The MMR Vaccine Is Not Associated With Risk for Autism.
    Ann Intern Med. 2019 Mar 5. pii: 2727209. doi: 10.7326/P19-0002.
    PubMed     Text format    

  4. OMER SB, Yildirim I
    Further Evidence of MMR Vaccine Safety: Scientific and Communications Considerations.
    Ann Intern Med. 2019 Mar 5. pii: 2727208. doi: 10.7326/M19-0596.
    PubMed     Text format    


    BMJ

  5. DYER O
    Philippines to charge Sanofi staff and government officials over dengue vaccine.
    BMJ. 2019;364:l1088.
    PubMed     Text format    


    Clin Infect Dis

  6. LIU X, Pitzer VE, Pollard AJ, Voysey M, et al
    The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  7. SAHA S, Islam MS, Sajib MSI, Saha S, et al
    Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  8. KAUFHOLD S, Yaesoubi R, Pitzer VE
    Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  9. MEIRING JE, Sambakunsi R, Moyo E, Misiri T, et al
    Community Engagement Before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  10. DEBELLUT F, Hendrix N, Pitzer VE, Neuzil KM, et al
    Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  11. MEIRING JE, Laurens MB, Patel P, Patel P, et al
    Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  12. VINK P, Ramon Torrell JM, Sanchez Fructuoso A, Kim SJ, et al
    Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: a Phase III, Randomized Clinical Trial.
    Clin Infect Dis. 2019 Mar 7. pii: 5370445. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. MILLER G
    Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens.
    Clin Infect Dis. 2019 Mar 7. pii: 5370442. doi: 10.1093.
    PubMed     Text format    

  14. JAMKA LP, Simiyu KW, Bentsi-Enchill AD, Mwisongo AJ, et al
    Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  15. HANSSON K, Rosdahl A, Insulander M, Vene S, et al
    Tick-borne encephalitis (TBE) vaccine failures: A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years.
    Clin Infect Dis. 2019 Mar 7. pii: 5370446. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  17. COLIN-JONES R, Shakya M, Voysey M, Theiss-Nyland K, et al
    Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  18. LUTHRA K, Watts E, Debellut F, Pecenka C, et al
    A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  19. THEISS-NYLAND K, Qadri F, Colin-Jones R, Zaman K, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  20. LAURENS MB, Sirima SB, Rotrosen ET, Siribie M, et al
    A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


    Infect Immun

  21. KENNEDY SC, Johnson AJ, Bharrhan S, Lindestam Arlehamn CS, et al
    Identification of mycobacterial ribosomal proteins as targets for CD4(+) T cells that enhance protective immunity in tuberculosis.
    Infect Immun. 2018 Jun 11. pii: IAI.00009-18. doi: 10.1128/IAI.00009.
    PubMed     Text format     Abstract available

  22. WANG Y, Wen Z, Pan X, Briles DE, et al
    Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Infect Immun. 2018 Jun 11. pii: IAI.00423-18. doi: 10.1128/IAI.00423.
    PubMed     Text format     Abstract available

  23. LIN YH, Chen Y, Smith TC 2nd, Karna SLR, et al
    Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available

  24. BATOOL M, Caoili SEC, Dangott LJ, Gerasimov E, et al
    Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available

  25. CHANDLER CE, Harberts EM, Laemmermann T, Zeng Q, et al
    In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available


    J Gen Virol

  26. EVANS JS, Selden D, Wu G, Wright E, et al
    Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.000998.
    PubMed     Text format     Abstract available


    J Immunol

  27. FOUGEROUX C, Turner L, Bojesen AM, Lavstsen T, et al
    Modified MHC Class II-Associated Invariant Chain Induces Increased Antibody Responses against Plasmodium falciparum Antigens after Adenoviral Vaccination.
    J Immunol. 2019 Mar 4. pii: jimmunol.1801210. doi: 10.4049/jimmunol.1801210.
    PubMed     Text format     Abstract available


    J Virol

  28. POLLARA J, Jones DI, Huffman T, Edwards RW, et al
    Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models.
    J Virol. 2019 Mar 6. pii: JVI.02119-18. doi: 10.1128/JVI.02119.
    PubMed     Text format     Abstract available


    JAMA

  29. HAMPTON T
    Vaccine Protects Mice From Emerging Tick-Borne Flaviviruses.
    JAMA. 2019;321:825-826.
    PubMed     Text format    


    Lancet Infect Dis

  30. FLANAGAN KL
    Will dual Japanese encephalitis and measles-rubella vaccination hinder measles and rubella eradication?
    Lancet Infect Dis. 2019 Mar 1. pii: S1473-3099(18)30688.
    PubMed     Text format    

  31. LI Y, Chu SY, Yue C, Wannemuehler K, et al
    Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.
    Lancet Infect Dis. 2019 Mar 1. pii: S1473-3099(18)30650.
    PubMed     Text format     Abstract available

  32. YIMING L, Zaiping J
    Lessons from the Chinese defective vaccine case.
    Lancet Infect Dis. 2019;19:245.
    PubMed     Text format    

  33. LADHANI SN, Borrow R, Andrews NJ
    Growing evidence supports 4CMenB effectiveness.
    Lancet Infect Dis. 2018;18:370-371.
    PubMed     Text format    


    Lancet Respir Med

  34. WHITE RG, Hanekom WA, Vekemans J, Harris RC, et al
    The way forward for tuberculosis vaccines.
    Lancet Respir Med. 2019;7:204-206.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  35. MBAEYI C, Alleman MM, Ehrhardt D, Wiesen E, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:225-230.
    PubMed     Text format     Abstract available


    Pediatrics

  36. PLOTKIN SA
    How to Prepare for Expert Testimony on the Safety of Vaccination.
    Pediatrics. 2019 Mar 6. pii: peds.2018-3578. doi: 10.1542/peds.2018-3578.
    PubMed     Text format    


    PLoS One

  37. IN HJ, Lim H, Lee JA, Lee SR, et al
    Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    PLoS One. 2018;13:e0202552.
    PubMed     Text format     Abstract available

  38. VAN DER WEELE P, Breeuwsma M, Donken R, van Logchem E, et al
    Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    PLoS One. 2019;14:e0212927.
    PubMed     Text format     Abstract available

  39. KIM HJ, Son HS, Lee SW, Yoon Y, et al
    Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    PLoS One. 2019;14:e0210477.
    PubMed     Text format     Abstract available

  40. SRIVASTAV A, O'Halloran A, Lu PJ, Williams WW, et al
    Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015.
    PLoS One. 2019;14:e0213431.
    PubMed     Text format     Abstract available

  41. KELLY JD, Worden L, Wannier SR, Hoff NA, et al
    Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of Congo, as of May 27, 2018.
    PLoS One. 2019;14:e0213190.
    PubMed     Text format     Abstract available

  42. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Text format     Abstract available


    Science

  43. WADMAN M
    Vaccination opponents target CDC panel.
    Science. 2019;363:1024.
    PubMed     Text format    


    Vaccine

  44. NDAWULA C JR, Sabadin GA, Parizi LF, da Silva Vaz I Jr, et al
    Constituting a glutathione S-transferase-cocktail vaccine against tick infestation.
    Vaccine. 2019 Feb 26. pii: S0264-410X(19)30246.
    PubMed     Text format     Abstract available

  45. ZEPEDA-CERVANTES J, Cruz-Resendiz A, Sampieri A, Carreon-Napoles R, et al
    Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
    Vaccine. 2019 Feb 26. pii: S0264-410X(19)30251.
    PubMed     Text format     Abstract available

  46. MEYER SB, Violette R, Aggarwal R, Simeoni M, et al
    Vaccine hesitancy and Web 2.0: Exploring how attitudes and beliefs about influenza vaccination are exchanged in online threaded user comments.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30223.
    PubMed     Text format     Abstract available

  47. PORTH JM, Wagner AL, Teklie H, Abeje Y, et al
    Vaccine non-receipt and refusal in Ethiopia: The expanded program on immunization coverage survey, 2012.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30252.
    PubMed     Text format     Abstract available

  48. ZHOU F, Xu J, Black CL, Ding H, et al
    Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30249.
    PubMed     Text format     Abstract available

  49. ROSSO A, Massimi A, De Vito C, Adamo G, et al
    Knowledge and attitudes on pediatric vaccinations and intention to vaccinate in a sample of pregnant women from the City of Rome.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30256.
    PubMed     Text format     Abstract available

  50. ZHANG D, Zhang Y, Wang Q, Lock J, et al
    The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30207.
    PubMed     Text format     Abstract available

  51. GIDUTHURI JG, Purohit V, Maire N, Kudale A, et al
    Influenza vaccination of pregnant women: Engaging clinicians to reduce missed opportunities for vaccination.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30240.
    PubMed     Text format     Abstract available

  52. KLEIN NP, Goddard K, Lewis E, Ross P, et al
    Long term risk of developing type 1 diabetes after HPV vaccination in males and females.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30258.
    PubMed     Text format     Abstract available

  53. AINSLIE KEC, Haber M, Orenstein WA
    Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Vaccine. 2019 Mar 1. pii: S0264-410X(19)30241.
    PubMed     Text format     Abstract available

  54. PAN SC, Hsieh SM, Lin CF, Hsu YS, et al
    A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(alphaK): A phase I study.
    Vaccine. 2019 Mar 2. pii: S0264-410X(19)30189.
    PubMed     Text format     Abstract available

  55. WATESKA AR, Nowalk MP, Lin CJ, Harrison LH, et al
    Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64years compared to the US general population.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30012.
    PubMed     Text format     Abstract available

  56. SATOH H, Tanaka-Taya K, Shimizu H, Goto A, et al
    Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30229.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: